Cargando…
Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study
BACKGROUND: Digoxin use was shown to be associated with an increased risk of cardiovascular events in atrial fibrillation (AF). We hypothesized that digoxin may affect cardiovascular risk by increasing platelet activation. METHODS AND RESULTS: Post hoc analysis of a prospective study of anticoagulat...
Autores principales: | Pastori, Daniele, Carnevale, Roberto, Nocella, Cristina, Bartimoccia, Simona, Novo, Marta, Cammisotto, Vittoria, Piconese, Silvia, Santulli, Maria, Vasaturo, Fortunata, Violi, Francesco, Pignatelli, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404445/ https://www.ncbi.nlm.nih.gov/pubmed/30571484 http://dx.doi.org/10.1161/JAHA.118.009509 |
Ejemplares similares
-
Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
por: Pastori, Daniele, et al.
Publicado: (2017) -
PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
por: Cammisotto, Vittoria, et al.
Publicado: (2020) -
Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016) -
Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study
por: Menichelli, Danilo, et al.
Publicado: (2021) -
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
por: Violi, Francesco, et al.
Publicado: (2022)